Your browser doesn't support javascript.
loading
Dose verification of virtual bolus application for helical tomotherapy.
Nwe, Saw Yu; Chitapanarux, Imjai; Nobnop, Wannapha.
Afiliación
  • Nwe SY; Graduate School, Medical Physics Program, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Chitapanarux I; Division of Radiation Oncology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Northern Thai Research Group of Radiation Oncology (NTRG-RO), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Nobnop W; Division of Radiation Oncology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Northern Thai Research Group of Radiation Oncology (NTRG-RO), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Electronic address: wannapha.n@cmu.ac.th.
Med Dosim ; 48(1): 16-19, 2023.
Article en En | MEDLINE | ID: mdl-36307296
ABSTRACT
The objective of the study is to verify the dose delivered on helical tomotherapy based on treatment plan with varying virtual bolus (VB) thickness. The target was localized on the ArcCHECK image by 3 mm margin from the phantom surface. The dimension of target, which includes the ArcCHECK's detectors, with the 4.0 cm width and length 12.0 cm along the phantom The 5 treatment plans were generated, 1 plan without VB application (NoVB) and the 4 plans with varying of VB thickness on the phantom surface by 0.5 cm (VB0.5), 1.0 cm (VB1.0), 1.5 cm (VB1.5), and 2.0 cm (VB2.0), in treatment planning but absent during irradiation. For measurement analysis, the ionization chamber and the ArcCHECK detectors were used for point dose and dose distribution by investigating the percentage of dose difference and the gamma passing rate. The VB thickness 0.5, 1.0 and 1.5 cm showed acceptable value with less than 2% for dose difference by 0.37% (VB0.5), -0.11% (VB1.0) and -0.37% (VB1.5) at the center of ArcCHECK. The accuracy of dose distribution showed an acceptable gamma passing rate of 99.8% (VB0.5), 100% (VB1.0), and 90.2% (VB1.5) for gamma criteria by 3%/3mm for absolute dose analysis. However, the gamma passing rate of VB2.0 down to 71.2% of absolute mode for gamma criteria by 3%/3mm. The treatment plans with VB thickness less than 15 mm deliver doses that are comparable to treatment plans without virtual bolus based on gamma analysis. However, the deviation showed a trend increasing when VB thickness increased. The VB2.0 was not acceptable for point dose and dose distribution verification by more than 2% dose difference and less than 90% of gamma passing rate.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Radioterapia de Intensidad Modulada Límite: Humans Idioma: En Revista: Med Dosim Asunto de la revista: RADIOTERAPIA Año: 2023 Tipo del documento: Article País de afiliación: Tailandia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Radioterapia de Intensidad Modulada Límite: Humans Idioma: En Revista: Med Dosim Asunto de la revista: RADIOTERAPIA Año: 2023 Tipo del documento: Article País de afiliación: Tailandia